Search Results

Danazol for the Treatment of Myelodysplastic Syndromes: A Systematic Review.

• Authors : Shah, Sangam; Yadav, Rukesh; Bhattarai, Abhinav

• Source: Oncology (08909091); Dec2023, Vol. 37 Issue 12, p480-487, 8p

Record details

CME. Bleeding Risk With SSRIs PART : Cardiovascular and Cerebrovascular Considerations.

• Authors : Robbins-Welty, Gregg A.; Tuck, Andrew N.; Marchant, Dale

Subjects: HEMORRHAGE risk factors; HEMORRHAGE complications; MEDICAL quality control

• Source: Psychiatric Times; Sep2023, Vol. 40 Issue 9, p35-39, 5p

Record details

AI Model Differentiates Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy.

• Authors : HIPPENSTEELE, ALANA

Subjects: MYELOFIBROSIS; THROMBOCYTOSIS; ARTIFICIAL intelligence

• Source: Pharmacy Practice in Focus: Oncology; Jan2024, Vol. 6 Issue 1, p33-35, 3p

Record details

Eltrombopag: a TPO receptor agonist for the treatment of chronic idiopathic thrombocytopenic purpura.

• Authors : Skirvin JA (AUTHOR)

• Source: Formulary. Oct2008, Vol. 43 Issue 10, p356-365. 8p.

Record details

Eltrombopag.

Subjects: THROMBOPENIC purpura treatment; PURPURA (Pathology) treatment; UNITED States. Food & Drug AdministrationUNITED States

• Source: Formulary. Oct2008, Vol. 43 Issue 10, p356-365. 8p.

Record details

Individualizing Treatment Plans and Optimizing Outcomes for Patients With MF and PV.

• Authors : Verstovsek, Srdan; Harrison, Claire

• Source: Oncology (08909091); Feb2021, Vol. 35 Issue 2, p93-98, 6p

Record details

Keeping Toxicity to a Minimum.

• Authors : Thomas, Felicity

Subjects: DRUG side effects; BONE marrow cells; PHARMACOLOGY

• Source: Pharmaceutical Technology Europe. Mar2020, Vol. 32 Issue 3, p16-18. 3p.

Record details

FDA Advisory Committee Supports Approval of Gene Therapy for Blood Disease.

• Authors : Myshko, Denise

Subjects: *COMMITTEES; BLOOD disease treatment; HEMOGLOBINSUNITED States. Food & Drug Administration

• Source: Formulary Watch. 6/11/2022, p1-1. 1p. 1 Color Photograph.

Record details

Implications of Mutation Profiling in Myeloid Malignancies: PART 2: Myeloproliferative Neoplasms and Other Myeloid Malignancies.

• Authors : Sokol, Kelsey; Tremblay, Douglas; Bhalla, Sheena

• Source: Oncology (08909091); May2018, Vol. 32 Issue 5, pe45-e51, 7p

Record details

A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis.

• Authors : Goodman, Aaron M.; Rust, Megan; Costello, Caitlin

• Source: Oncology (08909091); Feb2017, Vol. 31 Issue 2, p122-127, 5p

Record details